feed,title,long_url,short_url
Barron's,"Regeneron’s Covid-19 Antibody Isn’t a Slam Dunk for Profit, Analyst Says",https://www.barrons.com/articles/regeneron-covid-19-antibody-cocktail-profit-downgrade-roche-deal-51597930507?mod=RTA,https://j.mp/3hffPiB
